bioRxivCancer BiologyPreprint
A trimeric USP11/USP7/TCEAL1 complex stabilizes RNAPII during early transcription to sustain oncogenic gene expression
Markus Dehmer, Peter GallantiD, Steffi Herold, Giacomo CossaiD, Francesca ConteiD, Jan KösteriD, Florian SaueriD, Christina Schülein‐Völk, Carsten Patrick AdeiD, Raphael Silveira VidaliD, Caroline KiskeriD, Rogier VersteegiD, Petra BeliiD, Seychelle M. VosiD, Martin EilersiD, Gabriele BücheliD
Abstract
During early transcription, RNA polymerase II (RNAPII) undergoes a series of structural transitions controlled by cyclin-dependent kinases. Whether protein ubiquitylation and proteasomal degradation affect the fate of RNAPII close to promoters is less well understood. Here we show that the deubiquitylating enzyme USP11 and its heterodimeric partner USP7 form a trimeric complex with TCEAL1, a member of the poorly understood TCEAL (TCEA/TFIIS-like) protein family. TCEAL1 shares sequence homology with the RNAPII interaction domain of the TCEA/TFIIS elongation factor, which controls the fate of backtracked RNAPII. TCEAL1 stabilizes complexes of USP11 with USP7 and with RNAPII. TCEAL1 is recruited to core promoters when transcription elongation is blocked and globally enhances the chromatin association of RNAPII during early transcription. Mechanistically, the USP11/USP7/TCEAL1 complex competes with TFIIS for binding to core promoters and protects RPB8, an essential subunit of RNAPII, from degradation, likely preventing excessive TFIIS-mediated transcript cleavage and RNAPII disassembly. In neuroblastoma and other tumors, TCEAL1-dependent genes define a TGF beta-dependent gene expression program that is characteristic for mesenchymal and invasive tumor cell types, suggesting that the USP11/USP7/TCEAL1 trimer stabilizes RNAPII during early transcription to support a critical oncogenic gene expression program (190 words).
- organism: human
- assay: bulk RNA-seq
- research focus: cancer & tumor microenvironment
- research focus: gene regulatory network inference
- research focus: cell type annotation
- approach: experimental assay
- Citations
- 1
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- RNA Polymerase II Degradation Triggered by DNA Repair Occurs In Trans and Independently of how the Lesion is Recognised
Ramveer Choudhary, Juan Cristobal Muñoz, … Manuel Javier Muñoz·bioRxiv·Aug 30, 2024
- RNA Polymerase II CTD phosphatase Rtr1 prevents premature transcription termination
Melanie J. Fox, Jose F. Victorino, … Amber L. Mosley·PLoS GeneticsPeer-reviewed·Mar 18, 2020
- PAF1 facilitates RNA polymerase II ubiquitination by the Elongin A complex through phosphorylation by CDK12
G. Sanchez, J. Barbier, … S. Rouquier·bioRxiv·Sep 17, 2020
- RNA polymerase II assembly and mRNA decay regulation are mediated and interconnected via CTD Ser5P phosphatase Rtr1 in Saccharomyces cerevisiae
Ana Isabel Garrido-Godino, Abel Cuevas-Bermúdez, … Francisco Navarro·bioRxiv·Dec 23, 2020
- USP9X promotes the degradation of trapped translation factors on collided ribosomes
Wojciech Teodorowicz, Lukas‐Adrian Gurzeler, Oliver Mühlemann·bioRxiv·Aug 10, 2026
- INTS12 Bridges Integrator and NELF to Prevent the Release of Non-processive RNA Polymerase II Complexes
Laura Corso, S. Rivera, … Stephin J. Vervoort·bioRxiv·Jan 17, 2026